Therapeutics: Growth hormone-releasing hormone (GHRH) receptor

Endocrine/metabolic disease

INDICATION: Diabetes

In vitro and mouse studies suggest GHRH receptor agonists could improve engraftment of

Read the full 159 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE